{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:41:19Z","timestamp":1787002879938,"version":"build-2736575974"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T00:00:00Z","timestamp":1710460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T00:00:00Z","timestamp":1710460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP22kk0305020"],"award-info":[{"award-number":["JP22kk0305020"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP23ck0106872"],"award-info":[{"award-number":["JP23ck0106872"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007655","name":"Aichi Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007655","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum Genome Var"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Deleterious germline variants in the\n                    <jats:italic>BRCA1-associated ring domain<\/jats:italic>\n                    (\n                    <jats:italic>BARD1<\/jats:italic>\n                    ) gene moderately elevate breast cancer risk; however, their potential association with other neoplasms remains unclear. Here, we present the case of a 43-year-old female patient diagnosed with sigmoid colon adenocarcinoma whose maternal family members met the Amsterdam Criteria II for Lynch syndrome. Comprehensive multigene panel testing revealed a heterozygous\n                    <jats:italic>BARD1<\/jats:italic>\n                    exon 3 deletion.\n                  <\/jats:p>","DOI":"10.1038\/s41439-024-00267-y","type":"journal-article","created":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T22:01:42Z","timestamp":1710453702000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["BARD1 deletion in a patient with suspected hereditary colorectal cancer"],"prefix":"10.1038","volume":"11","author":[{"given":"Nobue","family":"Takaiso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4150-7938","authenticated-orcid":false,"given":"Issei","family":"Imoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyo","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Ouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Komori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroji","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,15]]},"reference":[{"key":"267_CR1","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/ng1296-430","volume":"14","author":"LC Wu","year":"1996","unstructured":"Wu, L. C. et al. Identification of a RING protein that can interact in vivo with the BRCA1 gene product. Nat. Genet. 14, 430\u2013440 (1996).","journal-title":"Nat. Genet."},{"key":"267_CR2","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1056\/NEJMoa1913948","volume":"384","author":"Breast Cancer Association Consortium","year":"2021","unstructured":"Breast Cancer Association Consortium et al. Breast cancer risk genes\u2014association analysis in more than 113,000 women. New Engl. J. Med. 384, 428\u2013439 (2021).","journal-title":"New Engl. J. Med."},{"key":"267_CR3","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1056\/NEJMoa2005936","volume":"384","author":"C Hu","year":"2021","unstructured":"Hu, C. et al. A population-based study of genes previously implicated in breast cancer. New Engl. J. Med. 384, 440\u2013451 (2021).","journal-title":"New Engl. J. Med."},{"key":"267_CR4","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology on Genetic\/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic version:2.2024. Available at https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/genetics_bop.pdf (2023)."},{"key":"267_CR5","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1053\/j.gastro.2015.05.006","volume":"149","author":"MB Yurgelun","year":"2015","unstructured":"Yurgelun, M. B. et al. Identification of a variety of mutations in cancer predisposition genes in patients with suspected Lynch syndrome. Gastroenterology 149, 604\u2013613.e20 (2015).","journal-title":"Gastroenterology"},{"key":"267_CR6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/gim.2014.89","volume":"17","author":"C Esteban-Jurado","year":"2015","unstructured":"Esteban-Jurado, C. et al. Whole-exome sequencing identifies rare pathogenic variants in new predisposition genes for familial colorectal cancer. Genet Med. 17, 131\u2013142 (2015).","journal-title":"Genet Med."},{"key":"267_CR7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13053-023-00246-4","volume":"21","author":"S Carrera","year":"2023","unstructured":"Carrera, S. et al. Germline heterozygous exons 8-11 pathogenic BARD1 gene deletion reported for the first time in a family with suspicion of a hereditary colorectal cancer syndrome: more than an incidental finding? Hered. Cancer Clin. Pr. 21, 2 (2023).","journal-title":"Hered. Cancer Clin. Pr."},{"key":"267_CR8","doi-asserted-by":"crossref","unstructured":"Brierley, J. D., Gospodarowicz, M. K. & Wittekind, C. (eds) The TNM Classification of Malignant Tumours, 8th edn. (Wiley Blackwell, Oxford, 2017).","DOI":"10.1002\/9780471420194.tnmc26.pub3"},{"key":"267_CR9","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0016-5085(99)70510-X","volume":"116","author":"HF Vasen","year":"1999","unstructured":"Vasen, H. F., Watson, P., Mecklin, J. P. & Lynch, H. T. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 116, 1453\u20131456 (1999).","journal-title":"Gastroenterology"},{"key":"267_CR10","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1038\/s41436-021-01187-w","volume":"23","author":"SE Lincoln","year":"2021","unstructured":"Lincoln, S. E. et al. One in seven pathogenic variants can be challenging to detect by NGS: an analysis of 450,000 patients with implications for clinical sensitivity and genetic test implementation. Genet. Med. 23, 1673\u20131680 (2021).","journal-title":"Genet. Med."},{"key":"267_CR11","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s41436-018-0033-5","volume":"21","author":"R Truty","year":"2019","unstructured":"Truty, R. et al. Prevalence and properties of intragenic copy-number variation in Mendelian disease genes. Genet. Med. 21, 114\u2013123 (2019).","journal-title":"Genet. Med."},{"key":"267_CR12","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000000650","volume":"8","author":"D McKnight","year":"2021","unstructured":"McKnight, D. et al. Multigene panel testing in a large cohort of adults with epilepsy: diagnostic yield and clinically actionable genetic findings. Neurol. Genet. 8, e650 (2021).","journal-title":"Neurol. Genet."},{"key":"267_CR13","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/gim.2017.37","volume":"19","author":"K Nykamp","year":"2017","unstructured":"Nykamp, K. et al. Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria. Genet. Med. 19, 1105\u20131117 (2017).","journal-title":"Genet. Med."},{"key":"267_CR14","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405\u2013424 (2015).","journal-title":"Genet. Med."},{"key":"267_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-09567-4","volume":"22","author":"YM Hawsawi","year":"2022","unstructured":"Hawsawi, Y. M. et al. BARD1 mystery: tumor suppressors are cancer susceptibility genes. BMC Cancer 22, 599 (2022).","journal-title":"BMC Cancer"},{"key":"267_CR16","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.1158\/1078-0432.CCR-11-0263","volume":"17","author":"JC Sporn","year":"2011","unstructured":"Sporn, J. C., Hothorn, T. & Jung, B. BARD1 expression predicts outcome in colon cancer. Clin. Cancer Res. 17, 5451\u20135462 (2011).","journal-title":"Clin. Cancer Res."},{"key":"267_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biocel.2015.12.008","volume":"72","author":"I Irminger-Finger","year":"2016","unstructured":"Irminger-Finger, I., Ratajska, M. & Pilyugin, M. New concepts on BARD1: regulator of BRCA pathways and beyond. Int J. Biochem. Cell Biol. 72, 1\u201317 (2016).","journal-title":"Int J. Biochem. Cell Biol."},{"key":"267_CR18","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1200\/JCO.2016.71.0012","volume":"35","author":"MB Yurgelun","year":"2017","unstructured":"Yurgelun, M. B. et al. Cancer susceptibility gene mutations in individuals with colorectal cancer. J. Clin. Oncol. 35, 1086\u20131095 (2017).","journal-title":"J. Clin. Oncol."},{"key":"267_CR19","doi-asserted-by":"publisher","first-page":"3721","DOI":"10.2147\/CMAR.S193985","volume":"11","author":"R Gong","year":"2019","unstructured":"Gong, R. et al. Mutation spectrum of germline cancer susceptibility genes among unselected Chinese colorectal cancer patients. Cancer Manag. Res. 11, 3721\u20133739 (2019).","journal-title":"Cancer Manag. Res."}],"container-title":["Human Genome Variation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41439-024-00267-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41439-024-00267-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41439-024-00267-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T03:21:16Z","timestamp":1736911276000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41439-024-00267-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,15]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["267"],"URL":"https:\/\/doi.org\/10.1038\/s41439-024-00267-y","relation":{},"ISSN":["2054-345X"],"issn-type":[{"value":"2054-345X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,15]]},"assertion":[{"value":"25 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Institutional Review Board of the Aichi Cancer Center (No. S05006). Informed consent was obtained from the patient for publication of the case details as well as genetic and genomic findings.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"11"}}